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Hepatitis C virus (HCV) infection is associated with chronic liver disease and currently affects about 3% of the world
population. Although much has been learned about the function of individual viral proteins, the role of the HCV p7
protein in virus replication is not known. Recent data, however, suggest that it forms ion channels that may be
targeted by antiviral compounds. Moreover, this protein was shown to be essential for infectivity in chimpanzee.
Employing the novel HCV infection system and using a genetic approach to investigate the function of p7 in the viral
replication cycle, we find that this protein is essential for efficient assembly and release of infectious virions across
divergent virus strains. We show that p7 promotes virus particle production in a genotype-specific manner most likely
due to interactions with other viral factors. Virus entry, on the other hand, is largely independent of p7, as the specific
infectivity of released virions with a defect in p7 was not affected. Together, these observations indicate that p7 is
primarily involved in the late phase of the HCV replication cycle. Finally, we note that p7 variants from different
isolates deviate substantially in their capacity to promote virus production, suggesting that p7 is an important
virulence factor that may modulate fitness and in turn virus persistence and pathogenesis.
Citation: Steinmann E, Penin F, Kallis S, Patel AH, Bartenschlager R, et al. (2007) Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS
Pathog 3(7): e103. doi:10.1371/journal.ppat.0030103
Introduction
Hepatitis C virus (HCV) is an enveloped virus that
presently has chronically infected about 170 million people
worldwide. One hallmark of HCV is its high degree of
sequence variability that likely contributes to its ability to
establish chronic infections. Different patient isolates are
grouped into six genotypes (GTs) and more than 100 subtypes
within the genus Hepacivirinae of the family Flaviviridae [1].
Persistent infection is associated with a variable degree of
liver damage often progressing in severity over the course of
decades. Accordingly, a large number of patients are at risk of
severe sequelae, including life-threatening conditions like
cirrhosis and hepatocellular carcinoma [2]. The best available
treatment, a combination of polyethylene glycol-conjugated
interferon alpha and ribavirin, is effective in only a fraction
of patients and is associated with severe side effects (reviewed
in [3]). A prophylactic or therapeutic vaccine is not available.
HCV possesses a positive strand RNA genome of about 9.6
kb composed of nontranslated regions at the 59 and 39
termini required for translation and RNA replication and a
single open reading frame encoding a large polyprotein (for a
recent review see [4,5]) (Figure 1A). A set of processing events
mediated by cellular enzymes and two viral proteases, NS2–3
and NS3-4A, liberate the individual viral protein core,
envelope glycoproteins 1 and 2 (E1, E2), p7, and non-
structural proteins NS2, NS3, NS4A, NS4B, NS5A, and NS5B.
Speciﬁc functions have been ascribed to most viral
proteins: core, E1, and E2 are the structural constituents of
the virus particle, and the viral genome is ampliﬁed by a
membrane-associated replicase complex consisting of non-
structural proteins NS3–NS5B; the role of the small mem-
brane polypeptide p7, however, is not deﬁned. While recent
in vivo experiments clearly indicate that p7 is essential for
infection [6], subgenomic HCV replicons do not contain p7,
demonstrating that it is not necessary for RNA replication [7].
Ectopically expressed, p7 primarily localized to the endo-
plasmic reticulum as an integral membrane protein and
displayed a topology with both N- and C-termini pointing
toward the endoplasmic reticulum lumen [8]. In line with this,
structure predictions suggest that p7 comprises two trans-
membrane (TM) helices connected via a short cytoplasmic
loop (Figure 1B) [8,9]. Recent in vitro studies indicate that p7
oligomerizes [10,11] and is capable of conducting ions across
artiﬁcial membrane systems in a cation-selective manner
[10,12,13]. Ion channel activity has been reported to be
speciﬁcally blocked by various compounds, suggesting that
this function may be amenable for development of antiviral
therapy [10,12,13]. Due to these properties, p7 has been
tentatively included in the family of viroporins comprising
proteins from diverse virus families, as for instance, 6k of
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Viroporins are generally small polypeptides that oligomerize,
thus forming hydrophilic pores that modulate membrane
permeability to ions in a way that is conducive for virus
propagation by promoting virus release, and in the case of
M2, also virus entry [14]. In this study, we used a genetic
approach to investigate the biological function of p7 in the
replication cycle of HCV. Our data indicate that this protein
is crucial for a late step in virus assembly and release, thus
providing functional evidence that p7 acts as a classical
viroporin in the course of HCV replication.
Results
p7 Is Required for Production of Infectious JFH1 Particles
Poor replication of HCV in cultured cells has long
hampered analysis of the virus life cycle. Only recently, this
impediment was overcome by the development of HCV
infection systems based on the JFH1 strain (GT 2a) or a cell
culture–adapted variant of the H77 isolate [15–18]. The scope
of the former system was extended by construction of
chimeras consisting of JFH1-derived replicase proteins and
structural proteins from heterologous isolates, allowing
comparative analyses of assembly and infection (Figure 1A)
[15,19]. In addition, insertion of reporter genes (e.g.,
luciferase) into these constructs (Figure 1A) now allows for
a fast and accurate measurement of replication and infection
[16,20,21].
To study the function of p7, we utilized the Luc-JFH1
reporter viruses, introduced mutations into the coding
region of p7, and assessed their impact with respect to RNA
replication and release of infectious virus particles. As
reference, we used a variant genome carrying a large in-
frame deletion in the E1-E2 coding region known to
inactivate release of virus particles [16]. For comparison with
previous observations, we replaced the two conserved basic
residues R33 and R35 located in the predicted cytoplasmic
loop of JFH1-derived p7 by alanine. These residues are known
to be essential both for in vivo infectivity [6] and in vitro ion
channel activity of p7 [22]. In addition, we mutated these
positions either individually or simultaneously to glutamine,
which due to its polarity is not expected to disturb the overall
topology of p7. Finally, we created a mutant lacking residues
1–32 of p7, directly connecting the C-terminal half of p7
carrying a signal-like sequence [8] to the C-terminus of E2
(Figure 1B). None of these alterations affected RNA repli-
cation in transfected Huh-7 cells (Figure 1C). In contrast, all
mutations inﬂuenced the number of infectious particles
released as indicated by lower amounts of core protein in
the culture ﬂuid (Figure 1D) and a decreased or abolished
transduction of luciferase reporter activity (Figure 1E). While
mutation of either R33 or R35 to glutamine resulted in a
partial defect, for all other mutants release of infectious
particles was no longer detectable, indicating that p7 is
required for the assembly and/or release of infectious virions.
Identification of Conserved Amino Acids Involved in the
Function of p7
To identify conserved amino acids likely essential for the
structure and/or function of p7, we investigated the varia-
bility of p7 by using a ClustalW alignment of 26 reference
genotypes representative of all major genotypes and subtypes
[1]. Based on this alignment we derived the amino acid
repertoire given in Figure 2A that lists the various amino
acids observed at every position of the p7 primary sequence
in decreasing order of frequency. In total, nine invariant
amino acids (labeled by an asterisk) emerged, among these
three cyclic amino acids. As cyclic residues, like histidine,
tyrosine and tryptophan are essential for the structure-
function relationships of other viral ion channel proteins
(e.g., M2 of inﬂuenza A virus [23] or Vpu of HIV-1 [24]);
therefore, we focused on fully conserved W30, Y42, and W48,
and in addition, on the more variable residue H31. To
minimize effects on topology and folding of p7, we
substituted these residues with phenylalanine, as this alter-
ation should conserve the predicted alpha-helical folding and
respect the cyclic character of these residues. In contrast,
phenylalanine is not expected to substitute for a direct
involvement of the given residue in ion channelling. In case
of H31, we created a set of mutants (H31Y, H31F, and H31L)
that are expected to have increasing impact if this residue
directly participates in ion channelling.
None of these alterations affected RNA replication in
transfected Huh-7 cells (Figure 2B). In contrast, release of
core protein (Figure 2C) and infectivity (Figure 2D) was
severely impaired for W30F and Y42F mutants but unchanged
or only slightly affected for all other mutants, suggesting that
W30 and Y42 are involved in the structure-function relation-
ship of p7.
Next, we investigated if these residues are important across
different HCV genotypes. To this end we introduced these
mutations into JFH1, the Jc1, and the Con1/C3 chimera, the
latter constructs comprising core, E1, E2, p7, and the amino
terminal portion of NS2 derived from J6CF (GT 2a) or Con1
(GT 1b), respectively [19]. As noted previously [19], JFH1, Jc1,
and Con1/C3 differ with respect to extent and kinetics of
accumulation of infectious virions (Figure 3A–3C, respec-
tively). Nonetheless, the impact of p7 mutations was
remarkably congruent. In all three viruses, the introduced
p7 mutation did not affect RNA replication, as evidenced by
comparable intracellular core protein expression 24 or 48 h
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Author Summary
The hepatitis C virus (HCV), a major human pathogen associated
with severe liver disease, encodes a small membrane protein
designated p7. Although recent reports indicated that p7 forms
channels conducting ions across membranes and is essential for
HCV infection, its exact role in the viral life cycle remained elusive. In
this study, we illustrate that HCV relies on p7 function for efficient
assembly and release of infectious progeny virions from liver cells.
Conversely, entry of HCV particles into new host cells is independent
of p7. This new evidence supports the recent proposal to include p7
into the family of viroporins that comprises proteins from diverse
viruses, for instance, HIV-1 and influenza A virus. Members of this
group of functionally related proteins form membrane pores that
promote virus release and in some cases also virus entry. Moreover,
we identify several conserved p7 residues crucial for functioning of
this protein. These amino acids possibly stabilize the structure of p7
or directly participate in channelling of ions. Interestingly, p7
variants from divergent patient isolates differ with regard to their
ability to promote virus production, suggesting that p7 modulates
viral fitness. Together these observations shed new light on
fundamental aspects of the HCV replication strategy.post-transfection (unpublished data). Conversely, partial
deletion of p7 abrogated production of infectious particles
(Figure 3A–3C), as did double mutation of basic amino acids
to alanine at position 33 and 35 in the event of JFH1 and
Con1/C3. In case of Jc1, the latter mutation delayed the
kinetics of virus accumulation and reduced the peak titer
attained almost 100-fold. Mutation of these residues to
glutamine also exerted a severe effect as accumulation of
infectivity was no longer detectable for Con1/C3, very low for
JFH1, and both delayed and reduced in the event of Jc1.
Finally, mutation of conserved W30 or Y42 residues
decreased the amount of infectivity produced for all three
viruses, albeit to a lesser extent than the mutants described
above.
It is worth noting that some mutations of p7 completely
blocked release of infectious particles while others exerted a
more or less pronounced defect, suggesting that either the
function of p7 was not completely inactivated by the latter, or
that the former mutants caused additional defects impacting
on virus production (e.g., signalase cleavage events at the E2-
p7 and/or p7-NS2 site). To distinguish between these
possibilities, we analyzed the processing of E2, p7, and NS2
by pulse-labeling of Huh-7.5 cells transfected with JFH1 or
the different JFH1-p7 mutants and immunoprecipitations
using an E2-speciﬁc monoclonal antibody (Figure 4). For all
p7 mutants, similar amounts of E2, E1, and NS2 were
precipitated when compared to JFH1, indicating that
processing at the E2-p7 and p7-NS2 junction occurs and
yields similar quantities of E1-E2 complexes. However,
mutant RR33/35AA, and in particular Dp7, displayed clearly
more unprocessed E2-p7-NS2 precursor compared to JFH1
and to all other mutants, indicating that signalase cleavage
was impaired by these mutations. Moreover, in case of Dp7,
no E2-p7 species could be detected and slightly less NS2 was
precipitated. Therefore, for RR33/35AA and Dp7 mutants, we
c a n n o tr u l eo u tt h a tt h ec o m p l e t eb l o c k a g eo fv i r u s
production was at least in part caused by a defect of
processing steps. However, in case of mutants RR33/35QQ,
W30F, and Y42F with the resolution of the employed assay,
processing was not affected, suggesting that impaired virus
Figure 1. Replication and Virus Production of Luc-JFH1 Genomes with Mutated p7
(A) Schematic representation of constructs used in this study. JFH1-derived 59 and 39 nontranslated regions are drawn as thick black lines and JFH1
proteins are depicted as open boxes. Jc1 and Con1/C3 have been described and comprise chimeric HCV polyproteins consisting of J6CF (gray boxes) or
Con1 (black boxes) fused with JFH1 [19]. The luciferase reporter virus genome Luc-JFH1 is depicted at the bottom [21].
(B) Topology model of E2, p7, and NS2 proteins. Signalase cleavage sites are denoted by black arrowheads. The location of conserved di-basic motif of
p7 is indicated. C- and N-terminal portion of the E2 TM domain are labeled N and C, respectively, while predicted TM helices 1 and 2 of p7 are labeled 1
and 2. Predicted NS2 TM helix 1 is labeled 1 while the two following predicted helices are labeled 2/3. Note that the crossover site in the virus chimeras
is located in the loop following TM helix 1 of NS2 (gray arrow) [19].
(C) Replication of Luc-JFH1 and given mutants in transfected Huh7-Lunet cells determined by luciferase reporter assays. Values given are expressed
relative to the reporter activity measured at 4 h which was set to one. Mean values of duplicate measurements and the standard errors are given.
(D) Release of core protein into the culture fluid 72 h post-transfection of cell given in (C). The gray lines indicate the cut-off of the ELISA and the
background luciferase activity measured in mock-infected cells, respectively; mean values of duplicate measurements and the standard errors are given.
(E) Infectivity associated with culture fluids harvested 72 h post-transfection determined by inoculation of Huh-7.5 cells and reporter assays. Mean
values of duplicate wells and the standard error of the means are given. The gray line denotes background relative light units measured in mock-
infected cells. Data presented in (C–E) were derived from a single experiment representative of five independent repetitions.
doi:10.1371/journal.ppat.0030103.g001
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Role of p7 in the HCV Replication Cycleproduction in these mutants is likely speciﬁcally due to
interference with the function of p7. In conclusion, these data
demonstrate that conserved amino acids R33/35, W30, and
Y42 are key residues involved in the functioning of p7 across
different HCV genotypes.
p7 Is Involved in the Assembly and Release of HCV
Particles
The M2 ion channel of inﬂuenza A virus is incorporated
into virus particles and is probably involved both in virus
assembly and entry (reviewed in [25]). Due to lack of
antibodies and difﬁculties in producing sufﬁcient virus, it is
not known if p7 is a constituent of HCV virions. Moreover, it
is unclear if p7 participates in virus entry. If this was the case,
viruses with mutant p7 should be impaired in entry and thus
exhibit lower speciﬁc infectivity (i.e., infectivity per given
number of physical particles). Therefore, we compared
particle release, accumulation of infectivity, and the speciﬁc
infectivity of particles between Jc1, the Jc1 p7 mutant KR33/
35QQ, and Jc1DHVR1, a derivative carrying a deletion of the
hyper-variable region 1 (HVR1) of E2, a domain known to be
involved in receptor interactions [26,27] (Figure 5A). The p7
mutation (KR33/35QQ) suppressed release of particles,
whereas deletion of HVR1 did not affect particle release
(Figure 5A, left). Both mutants, however, displayed impaired
infectivity, likely due to disturbed receptor interaction, and
thus diminished speciﬁc infectivity in the case of Jc1DHVR1
and lower numbers of released particles for the KR33/35QQ
mutant (Figure 5A, middle). To rigorously assess if the latter
mutant is additionally impaired in virus entry, we diluted the
Jc1 and Jc1DHVR1 culture ﬂuids to the same quantity of core
protein as present in the Jc1-KR33/35QQ preparation and
titrated the infectivity associated with this number of physical
particles (i.e., speciﬁc infectivity, Figure 5A, right). While
Jc1DHVR1 particles were about 10-fold less infectious than
Jc1 particles, the KR33/35QQ mutant was indistinguishable
from Jc1, indicating that this p7 mutation did not affect the
capacity of these particles to enter Huh-7 cells. It is of note
that these results are in agreement with the data obtained
with p7 mutants in the context of Luc-JFH1 reporter viruses
(Figures 1 and 2). In this setting, mutations R33Q, R35Q,
W30F, and Y42F impaired production of infectious particles
and release of core protein in a commensurate manner,
indicating that the speciﬁc infectivity of these virions was not
affected by the respective mutations in p7.
The data presented so far indicate that mutation of p7
decreases the number of secreted infectious particles. This
may be attributable to defective virion assembly or impaired
release of virions. To distinguish between these possibilities,
we compared the quantity of intracellular infectious viruses
(prepared by repetitive cycles of freeze and thaw [28]) and
extracellular infectious viruses produced upon transfection
of Huh-7 cells with Jc1 and the p7 mutants W30F, Y42F,
KR33/35QQ, KR33/35AA, and Dp7 (Figure 5B). As reference,
Figure 2. Identification of Conserved Amino Acids Essential for p7 Functioning
(A) Amino acid repertoire of the 26 representative p7 sequences of confirmed HCV genotypes/subtypes (listed with accession numbers in Table 1 in [1]).
Helical turn and loop regions deduced from the nuclear magnetic resonance structure analysis of a p7 GT 1b variant (F. Penin, unpublished data) are
depicted at the top, and the primary sequence of JFH1-derived p7 (GT 2a) in combination with a ruler indicating amino acid numbers with respect to p7
and the complete JFH1 genome are given below. The degree of conservation can be inferred by the extent of variability (with the observed amino acids
listed in decreasing order of frequency from top to bottom) and the similarity index according to ClustalW convention (asterisk, invariant; colon, highly
similar; dot, similar) [46]. Residues mutated in this study are shaded in gray.
(B) Replication of Luc-JFH1 and given mutants in transfected Huh7-Lunet cells determined as described above.
(C) Release of core protein and (D) infectivity into the culture fluid 72 h post-transfection of cell given in (B). The gray lines indicate the cut-off of the
ELISA and the background luciferase activity measured in mock-infected cells, respectively. A representative experiment of at least four independent
repetitions is given.
doi:10.1371/journal.ppat.0030103.g002
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the conserved lysine in the TM domain of E1 (K179Q;
designated E1-TMD). Since K179 of E1 is involved in
heterodimerization between E1 and E2 [29], likely a prereq-
uisite for virus formation, we assumed that its mutation
should primarily affect assembly of infectious virions. Figure
5B displays the total infectivity (summation of extracellular
and cell-associated infectivity) produced upon transfection of
these constructs (left), the quantity of cell-associated and
extracellular infectivity (middle), and where applicable, the
percentage of cell-associated and released infectivity ex-
pressed relative to the total amount of infectivity (right).
As expected, p7 mutations W30F and Y42F reduced total
infectivity by 2- and 5-fold only, while for mutants KR33/
35QQ and KR33/35AA, and the E1 mutant E1-TMD, total
yields of infectious virions were heavily impaired (;100-,
1,000-, and 500-fold, respectively). In case of E1-TMD the
numbers of intra- and extracellular infectious virions were
decreased in a commensurate manner (;500-fold) when
compared to Jc1, indicating that this mutation affected
assembly and not the efﬁciency of virus release. Accordingly,
the ratio of intracellular to extracellular infectivity was
indistinguishable from Jc1 with much more infectious
particles liberated into the culture ﬂuid (;99%) than
retained intracellularly (Figure 5B, right). In contrast,
mutation of KR33/35 to either QQ or AA primarily decreased
the quantity of infectious virions released from the cells. As a
consequence, these mutants displayed a much higher pro-
portion of cell-associated particles when compared to Jc1 and
Jc1-E1-TMD (;30%–40% as compared to 1%–2%) indicating
that these p7 mutants were impaired both in assembly and
release of infectious viruses. For mutants W30F and Y42F,
which produced only slightly or moderately less infectious
virions, we did not observe a signiﬁcantly changed ratio
between extra- and intracellular virions. Finally, Jc1Dp7 did
not produce any infectivity, indicating that this mutation is
lethal to proper virus production. In summary, these data
indicate that p7 is not only essential for efﬁcient assembly of
infectious virus but also critical for effective export of
infectious particles.
p7 Variants Differ with Regard to Their Ability to Promote
Virus Production
Why HCV chimeras with J6CF-derived core-to-NS2 pro-
teins in place of the homologous JFH1 proteins produce
much higher virus titers is unknown. Based on the observa-
tion that p7 is a key determinant of efﬁcient assembly and
virus egress, we speculated that this may be linked to the
J6CF-derived p7. Thus, we constructed additional chimeras
by transferring J6CF-derived p7 to JFH1 or Con1/C3 (Figure
6). Moreover, in the Jc1 backbone, we substituted J6CF p7 for
the one of JFH1 or Con1. In line with the above hypothesis,
interchange of p7 proteins profoundly altered the efﬁciency
of virus production of the different virus chimeras while not
affecting RNA replication, as evidenced by comparable
intracellular core protein expression 24 h post-transfection
(unpublished data). In case of intragenotypic GT 2a chimeras
(JFH1 and J6CF), J6CF p7 conferred much better growth
properties (Figure 6, top). More speciﬁcally, transfer of this
p7 variant into JFH1 increased the peak titer more than 20-
fold over JFH1. In contrast, incorporation of JFH1 p7 into the
context of Jc1 delayed accumulation of infectivity and
reduced the peak titer about 10-fold compared to Jc1. Thus,
for these GT 2a chimeras, properties inherent to J6CF p7
bestow much more rapid and efﬁcient virus production.
However, this attribute of J6CF p7 does not promote virus
production independent of virus strain as is evident from the
intergenotypic transfer of J6CF p7 to Con1/C3 (GT 1b) which
Figure 3. Accumulation of Infectivity upon Transfection of JFH1 or
Chimeras Carrying Varying p7 Mutations
Huh-7.5 cells were transfected with (A) JFH1, (B) Jc1, or (C) Con1/C3 wild-
type constructs or given p7 mutants in the context of the respective
virus. Cell-free supernatants were harvested and titrated by using a
limiting dilution assay. The gray bars represent the detection limit of the
limiting dilution assay.
doi:10.1371/journal.ppat.0030103.g003
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Role of p7 in the HCV Replication Cyclesuppresses virus production (Figure 6, bottom). In this case,
likely genetic incompatibility between GT 2a p7 and GT 1b
structural proteins or the N-terminal NS2 domain of GT 1b
limits virus production.
Beside this, we observed subtle changes at the level of
processing in the E2-p7-NS2 region in case of the Jc1/p7-JFH1
and Jc1/p7-Con1 chimeras that carry JFH1-derived and Con1-
derived p7 in place of the autologous J6CF p7, respectively
(Figure 7; compare lane 1 with lanes 2 and 8). Finally, when
transferring J6CF-p7 to the Con1/C3 chimera we noted a
minor alteration of the E2/E2p7 signal that may indicate a
change of processing at the E2-p7 junction or an altered
glycosylation of these proteins (Figure 7, lanes 6 and 7). This
modiﬁed processing may, in addition to genetic incompati-
bility, limit production of infectious virions, thus complicat-
ing direct comparison of the ability of a given p7 variant to
promote virus production. Nevertheless, at least within a
given genotype, the pronounced gain-of-function when
exchanging JFH1 p7 for the one encoded by J6CF clearly
indicates that p7 from divergent virus strains possesses
different capabilities to facilitate virus production, and that
J6CF-p7 is more active in this regard than JFH1-p7.
Discussion
Accumulating evidence indicates that p7 is capable of
forming ion channels [10,12,13]. Based on this property and
its predicted structure and topology [8,9] it was ascribed to
the family of viroporins. By deﬁnition, these are small, rather
hydrophobic viral proteins which tend to oligomerize to form
hydrophilic pores that modulate membrane permeability
conducive for virus propagation [14]. Currently, a number of
proteins from divergent viruses are assigned to this family,
among them prominent examples like inﬂuenza A virus M2,
HIV-1 Vpu, and 6k of alpha-viruses. While M2 facilitates both
virus entry and exit, Vpu and 6k only assist virus assembly and
release. Although not absolutely essential, they greatly
facilitate these steps in the viral replication cycle. Accord-
ingly, inactivation of 6k or Vpu diminishes yields of infectious
particles in the culture ﬂuid and increases the quantity of
cell-associated particles [30–34].
By using a set of viruses carrying speciﬁc p7 mutations, we
found that this protein is involved in assembly and release of
infectious virus particles; thus providing strong functional
evidence that p7 acts as classical viroporin in the replication
cycle of HCV. This conclusion rests on the lower yields of
infectious particles that we obtained upon transfection of
viruses with several different p7 mutations. Moreover, when
p7 was mutated we noted a much higher ratio of cell-
associated to free virus particles as compared to Jc1 or a
mutant with impaired glycoprotein heterodimerization. This
is reminiscent of the phenotype caused by 6k or Vpu
mutation and thus indicates that p7, like Vpu and 6k, acts
at a very late step of virus assembly, possibly facilitating virus
budding.
The speciﬁc infectivity of viruses with mutant p7, however,
was not reduced, suggesting that p7 does not play a role
during virus entry. Although we cannot exclude that the
mutations analyzed may not affect a putative function of p7
in virus entry, this is unlikely as several mutations in different
regions of the protein impaired virus release but did not
change the speciﬁc infectivity of released particles (compare
Figures 1, 2, and 4). It is worth mentioning that based on these
data it is unlikely that the introduced mutations act by
inactivating cis-active RNA packaging signals as this would
likely result in a decrease of speciﬁc infectivity of secreted
virions due to impaired packaging of genomic RNA. In
agreement with this notion, we have observed efﬁcient trans-
packaging of subgenomic HCV replicons (comprising the
nontranslated regions and the coding region of NS3 to NS5B
Figure 4. Processing of the E2-p7-NS2 Region of JFH1 and Various p7 Mutants
Huh-7.5 cells were transfected with indicated constructs and after 24 h pulse-labeled with [35S] methionine/cysteine-containing medium, lysed
immediately, or chased for 4 or 8 h. Cells transfected with a subgenomic JFH1 replicon encoding HCV proteins NS3–NS5B only (SG-JFH1) served as
negative control. HCV proteins were immunoprecipitated using an antibody monospecific for E2 and are identified by arrows on the left. The positions
of the molecular weight standard are given on the right. Arrowheads to the left point to the respective precursors and mature proteins detected.
Arrows within the figure point out obvious alterations in protein processing.
doi:10.1371/journal.ppat.0030103.g004
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Role of p7 in the HCV Replication Cycleonly) by full-length helper viruses, demonstrating that the
core to NS2 region of the HCV genome does not carry cis-
active RNA signals absolutely essential for genome packaging
(E. Steinmann and T. Pietschmann, unpublished data).
Besides this, we have shown that replacement of the two
conserved basic amino acids within the cytoplasmic loop of
p7 with either alanine or glutamine dramatically suppressed
production of infectious particles of GT 1b and GT 2a viruses.
Interestingly, Sakai et al. found that a similar mutant (KR33/
35IS) in the context of H77c (GT 1a) is not infectious in
chimpanzee [6]. Moreover, Grifﬁn et al. recently reported
that p7 derived from the infectious molecular clone HC-J4
(GT 1b; [35]) substituted for M2 in a cell-based ion channel
assay whereas the KR33/35AA mutant did not [22]. It is of
note that in our pulse-labeling experiments of transfected
Huh-7 cells producing HCVcc, we have observed a slight
defect at the level of E2-p7-NS2 processing for the JFH1 p7
mutant RR33/35AA. Therefore, we cannot exclude that the
dramatic effect of this mutation may at least in part be caused
by aberrant processing events at the E2-p7 and p7-NS2
junction. In fact, mutation of the di-basic motif close to the
cytoplasmic loop of p7 by hydrophobic ala residues is
expected to disturb the signal-like function of the C-terminal
half of p7, and also possibly p7 topology. Conversely, their
mutation to hydrophilic Gln residues (RR33/35QQ) is not
expected to exert these adverse effects, and consequently we
did not detect a defect at the level of E2-p7-NS2 processing.
Therefore, for the latter mutant the pronounced defect in
virus production is likely primarily attributable to a loss of p7
function. In synopsis with our data, these results highlight the
importance of the conserved di-basic motif at the C-terminus
of the ﬁrst TM helix of p7, and moreover, they provide a
rational explanation why the mutant described by Sakai et al.
was noninfectious in vivo. It is worth mentioning that our
data are similar to those of Harada et al. who observed that p7
of the bovine viral diarrhea virus (BVDV), a relative of HCV
belonging to the genus Pestivirinae within the family Flavivir-
idae, is required for production of infectious particles [36].
Despite little sequence similarity, the BVDV equivalent also
contains two hydrophobic regions connected by a polar
segment containing several conserved charged residues.
Remarkably, mutation of these abrogated production of
Figure 5. Specific Infectivity and Efficiency of Virus Assembly and Release of Jc1 with Mutated p7
(A) Huh7-Lunet cells were transfected with indicated genomes, and 48 h post-transfection culture fluid was harvested for quantification of core protein
by ELISA (left panel) and infectivity by TCID50 assay (middle). The specific infectivity of the given viruses was determined by dilution of Jc1 and DHVR1 to
the same quantity of core protein as KR33/35QQ (444 pg) and titration by using the limiting dilution assay.
(B) Cells were transfected as in (A) and 48 h post-transfection supernatants were collected. In parallel, virus-producing cells were washed and lysedb y
repetitive cycles of freeze and thaw. Extracellular (white bars) and intracellular infectivity (gray bars) were determined by limiting dilution assay and are
depicted in the middle. The panel on the left shows the total infectivity per plate, whereas the percentage of cell-associated and released infectivity
expressed relative to the total amount of infectivity is given in the right. The gray lines denote the detection limits of the ELISA and the limiting dilution
assay, respectively. Mean values of five independent experiments and the standard deviation of the means are presented.
doi:10.1371/journal.ppat.0030103.g005
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Role of p7 in the HCV Replication Cycleinfectious BVDV particles [36]. This indicates that these
proteins may adopt a similar topology and act as functional
homologs and suggests that both viruses rely on viroporin
function for efﬁcient virus assembly and particle export.
To deﬁne further amino acids and protein domains
involved in the function of p7, we performed an exhaustive
analysis of sequence conservation based on reference
sequences of all major genotypes. Site-directed mutagenesis
revealed that W30 in close proximity to the di-basic motif and
Y42 at the beginning of TM helix 2 are essential for p7
functioning across different genotypes. On the other hand,
W48 and H31 appear to be less essential, as mutation of these
residues did not signiﬁcantly affect particle production.
Without a high resolution structure of p7 it is difﬁcult to
predict how these changes inﬂuence p7 conformation and/or
function. In principle, interactions between p7 TM-helices,
p7 monomers, or other viral or cellular proteins may be
affected. Alternatively, ion channelling, or possible gating
mechanisms required for proper function may be impaired.
Interestingly, when we mapped the residues analyzed in this
study on a model of JFH1-derived p7, which is based on the
secondary structure of a GT 1b p7 variant recently solved by
nuclear magnetic resonance spectroscopy (Figure S1 and F.
Penin et al., unpublished data), the side chains of W30 and
Y42 interacted by the stacking of their aromatic rings
directed toward each other at the interface between TM
helix 1 and 2. In contrast, the side chains of the conserved
Figure 6. Accumulation of Infectivity upon Transfection of GT 2a and GT
1b Viruses with J6CF-Derived p7 Proteins
The color coding is as in Figure 1 with open boxes representing JFH1,
gray boxes J6CF, and black boxes Con1 proteins. Accumulation of
infectivity upon transfection is given below. The gray line denotes the
detection limit of the limiting dilution assay. A representative experiment
of at least two repetitions is depicted.
doi:10.1371/journal.ppat.0030103.g006
Figure 7. Processing of the E2-p7-NS2 Region of JFH1, Jc1, Con1/C3, and
Various Chimeras
Huh-7.5 cells were transfected with indicated constructs. 24 h post-
transfection, cells were labeled with [35S] methionine/cysteine-contain-
ing medium overnight and then lysed immediately. HCV proteins were
immunoprecipitated using an antibody monospecific for E2. The
positions of the molecular weight standard are given on the right.
Arrowheads to the left point to the respective precursors and mature
HCV proteins detected. Arrows within the figure point out alterations in
protein processing. Note that Con1-derived E1 displays a lower electro-
phoretic mobility than E1 from JFH1 and J6CF.
doi:10.1371/journal.ppat.0030103.g007
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helix 1, point away from the p7 monomer toward the
negatively charged lipid head groups at the cytoplasmic face
of the membrane. Therefore, this model structure indicates
that W30 and Y42 interaction is essential for the stabilization
of p7 TM helix packing, whereas the di-basic motif may be
directly involved in ion channelling, as supported here by the
glutamine mutants. Alternatively or in addition, these basic
residues may stabilize a proper orientation of p7 with respect
to the membrane via electrostatic interactions with negatively
charged phosphate of lipid polar head groups.
Finally, it is interesting to note that the apparently highly
efﬁcient J6CF p7 variant boosted virus production in the
context of the homologous GT 2a strain JFH1, but almost
abrogated accumulation of infectious virions in the environ-
ment of the more distantly related GT 1b virus Con1/C3. On
one hand, these data indicate that p7 variants promote virus
assembly and release with rather different potency, suggest-
ing that p7 signiﬁcantly contributes to viral ﬁtness and in
turn may affect virus persistence and pathogenesis. On the
other hand, based on these results we conclude that
interactions of p7 with other viral structural proteins and/
or NS2 are important for p7 to function in promoting virus
assembly and release. This notion is supported by several
lines of evidence: First, Haqshenas et al. recently reported
that an intergenotypic JFH1 chimera with GT 1b p7 was
viable yet attenuated when compared to JFH1 [37]. Second, Yi
et al. described that an intergenotypic virus chimera
comprising H77 and JFH1 segments fused at a position
within NS2 acquired compensatory mutations residing in p7
and NS2 [38]. Third, when we mapped the optimal junction
for Con1-JFH1 chimeras, a crossover downstream of the ﬁrst
TM-helix of NS2 was superior to a junction at the C-terminus
of p7 [19]. And ﬁnally, Sakai et al. noted that an H77c chimera
with J6CF p7 was only infectious in chimpanzee when the
endoplasmic reticulum–resident N- and C-terminal loop
regions were derived from H77 [6], suggesting that geno-
type-speciﬁc interactions may at least in part be mediated by
these domains.
In summary, we show that HCV p7 promotes a late step of
assembly and release of infectious virions. These data support
the notion that p7 acts as viroporin likely similar to its BVDV
equivalent, to alpha-virus 6k, and HIV-1 Vpu. In addition, we
show that virus isolates differ in regard to their dependence
on p7 function and the potency of the respective p7 variants
to promote virus assembly and release. The stimulatory effect
of p7 on virus production is controlled by the genotype of
other viral proteins implying that genotype-speciﬁc inter-
actions of p7 govern the efﬁciency of assembly. Finally, the
knowledge of conserved residues involved in the function of
p7 should help to evaluate in vitro assays useful for screening
of p7-speciﬁc antiviral compounds and to further dissect the
mechanism of HCV assembly.
Materials and Methods
Plasmids. Plasmids pFK-JFH1, pFK-Jc1, pFK-Con1/C3, and pFK-
Luc-JFH1 have been described recently [16,19]. To facilitate muta-
genesis, we introduced a silent XbaI site at the beginning of the p7
coding region of each of these constructs. This modiﬁcation did not
affect HCV RNA replication or virus production (unpublished data).
Individual mutations were intr o d u c e db ys t a n d a r dP C R - b a s e d
techniques and veriﬁed by sequencing. Detailed sequence informa-
tion is available upon request.
Cell culture and infectivity assay. Huh-7 cell–derived cell clones
Huh-7.5 and Huh7-Lunet, which are highly permissive for HCV
replication [39,40], were used for transfection and infection assays.
Luciferase reporter virus-associated infectivity was determined as
described [21]. Authentic viruses were titrated by using a limiting
dilution assay on Huh-7.5 cells [15] with a few minor modiﬁcations
[41]. The tissue culture 50% infectivity dose (TCID50) was calculated
based on the methods described [42,43].
In vitro transcription, electroporation, and transient HCV repli-
cation assay using authentic and reporter genomes. These methods
have been described elsewhere [16,41]. When genomes without
reporter gene were transfected, we controlled transfection and
replication efﬁciency of these genomes by determining intracellular
core protein expression 24 h or 48 h post-transfection.
Freeze and thaw lysates of HCV-transfected cells. Huh7-Lunet cells
were transfected with parental and recombinant Jc1 genomes; 48 h
post-transfection cell culture supernatants were harvested and virus
titers determined by TCID50. Cell-associated infectivity was prepared
essentially as described [28]. Brieﬂy, cells were extensively washed
with PBS, scraped and centrifuged for 5 min at 400 3 g. Cell pellets
were resuspended in 1 ml of DMEM containing 5% FCS and
subjected to three cycles of freeze and thaw using liquid nitrogen
and a thermo block set to 37 8C. Samples were then centrifuged at
10,0003g for 10 min at 4 8C to remove cell debris, and cell-associated
infectivity was determined by TCID50 assay.
Metabolic radiolabeling of proteins and immunoprecipitation.
Huh-7.5 cells were transfected with indicated HCV genomes. After
24 h, cells were washed with PBS, starved in methionine-free medium
for 60 min, and incubated for 6 h in methionine-free DMEM
supplemented with 100 lCi/ml of Express Protein labeling mix
(Perkin Elmer, http://www.perkinelmer.com/). Cells were lysed either
directly or washed several times and incubated in complete DMEM
for time periods given in the text. Cell lysates were prepared by using
NPB (50 mM, Tris-Cl [pH 7.5], 150 mM NaCl, 1% Nonidet P-40, 1%
sodium deoxycholate, and 0.1% SDS), lysates were cleared by
centrifugation at 13,800 3 g for 15 min at 4 8C. The cleared lysates
were used for immunoprecipitation using E2-speciﬁc antibody AP33
[44]. Immuncomplexes were resolved by denaturing SDS-PAGE and
detected by autoradiography.
Quantitative detection of HCV core protein by ELISA. HCV C
protein was quantiﬁed using the Trak-C Core ELISA (Ortho Clinical
Diagnostics, http://www.orthoclinical.com/) as recently described [21].
Amino acid sequence analyses. Sequence analyses were performed
using the euHCVdb database Website facilities at Institute de
Biologie et Chimie des Prote ´ines (IBCP) (http://euhcvdb.ibcp.fr/)
[45]. Multiple sequence alignments and amino acid conservation
were carried out with the ClustalW program using default parameters
[46]. The repertoire of residues at each amino acid position and their
frequencies observed in natural sequence variants were computed by
using a program developed by our laboratory (C. Combet, F. Dorkelt,
F. Penin, and G. Deleage, unpublished data).
Supporting Information
Figure S1. Model of JFH1-Derived p7
This model was constructed by using the secondary structure of a GT
1b p7 variant recently solved by nuclear magnetic resonance as a
template (F. Penin et al., unpublished data) and Swiss Model server
facilities (http://www.expasy.ch/swissmod/). The structure backbone is
represented as ribbon and only the side chains of amino acids
mutated in this study and of the residues likely involved in inter-helix
interactions are shown. Color code is as follows: Ser, Thr, Asn, and
Glu (yellow); Cys (green); His (cyan); Arg and Lys (blue); Glu (red); Trp
(magenta); Tyr (purple); any other hydrophobic residue (gray). This
ﬁgure was generated with Rasmol 2.7 program. The phospholipid
bilayer is schematically represented.
Found at doi:10.1371/journal.ppat.0030103.sg001 (74 KB PDF).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank/) accession num-
bers for the HCV genomes used in this study are JFH1 (AB047639),
J6CF (AF177036), and Con1 (AJ238799).
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